Labiotech.eu

servier lonsurf colorectal cancer trifluridine tipiracil

News and Trends 28 Apr 2016

EU approves Combo-Drug for Metastatic Colorectal Cancer

Servier sees one of its combo-drug (trifluridine/tipiracil) approved by the European Commission, after showing a 2 month improvement in overall survival for metastatic Colorectal cancer. The largest private Pharma from France, Servier has well-known stake in innovative oncology therapies due to its role in the restructuring of Cellectis as a universal CAR-T Biotech – which looks extremely […]

April 28, 2016 - 2 minutesmins - By Denise Neves Gameiro

wheat meiogenix spix epigenetics cambridge bbrsc

News and Trends 28 Apr 2016

French Biotech and Cambridge to improve Food Security with UK Grant

Meiogenix and the University of Cambridge will get fresh money to investigate how epigenomics impacts crop diversity – and how it can be engineered for better yields of wheat. Based in Paris, Meiogenix is developing breeding technologies – which already caught the eye of Bayer Crop Science. One of its platforms is SpiX, which increases the […]

April 28, 2016 - 2 minutesmins - By Denise Neves Gameiro

interview biotrinity labiotech dementia fund

News and Trends 28 Apr 2016

Interviewing the CSO of the newly €90M fund willing to finally tackle Dementia

I had the chance to talk with Tetsuyuki Maruyama, the CSO of the relatively new Dementia Discovery Fund – our final interview for #BioTrinity2016 in London. The high risk nature of doing trials for Dementia patients means in the past the market for this area of Neurodegenerative disease has been tough. However, the need for […]

April 28, 2016 - 1 minutemin - By Philip Hemme

morphosys novartis muscle simb bimagrumab

News and Trends 27 Apr 2016

‘Disappointing results’ for Novartis & MorphoSys phase III in Muscle Disease

MorphoSys confirms that its antibody (bimagrumab) failed to meet the primary endpoint of a phase IIb/III trial for a muscle disease (sIBM), conducted by Novartis. Sad news for Novartis and MorphoSys. The two companies are developing bimagrumab for muscle diseases, as part of their ongoing collaboration, which has already resulted in 11 programmes. Bimagrumab was initially […]

April 27, 2016 - 2 minutesmins - By Denise Neves Gameiro

pharnext pleodrug charcot marie tooth cmt1a

News and Trends 27 Apr 2016

French Pleodrug for Rare Neurological Disease opens up phase III trial in US

Pharnext is opening their first US study sites for a phase III trial in a rare neuropathy – a milestone in the development of Pharnext’s leading candidate. Based in Paris (France), Pharnext is developing new therapies for neurological conditions, including rare diseases such as Charcot-Marie-Tooth Disease. Pharnext uses network pharmacology to discover synergistic combinations of drugs […]

April 27, 2016 - 2 minutesmins - By Denise Neves Gameiro

txcell ospedale san raffaele lupus nephritis car treg

News and Trends 27 Apr 2016

CAR-T for Lupus with French-Italian Partnership

TxCell and Ospedale San Raffaele have partnered up to research a new treatment for Lupus, based on engineered regulatory T-cells (CAR-Treg). TxCell is developing immunotherapies based on the discovery of a type of T-cells that have anti-inflammatory properties – regulatory T lymphocytes (Tregs). Tregs have already yielded two candidates. Osave is currently on phase IIb […]

April 27, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 27 Apr 2016

Interviewing the CEO who uses Probiotics as Needle-free Vaccines

This is my first interview from BioTrinity 2016 in London. I met with Tom Johnston, CEO of Mucosis, to learn more about the needle-free vaccine platform he is developing. Mucosis is a biotechnology company based in Gröningen, Netherlands (a city we covered here for its medtech innovation). It was founded in 2007 and has raised over €20M so […]

April 27, 2016 - 1 minutemin - By Philip Hemme

News and Trends 26 Apr 2016

Illumina is Suing over NGS Prenatal Screening… Again

Genoma is being sued by Illumina over four patents covering technology for prenatal testing, that uses NGS to diagnose fetal defects. After suing Oxford Nanopore over porin technology, Illumina is back to another contentious field – their patents for a type of non-invasive prenatal testing (NIPT). Illumina has filed a patent infringement suit in the Federal […]

April 26, 2016 - 2 minutesmins - By Denise Neves Gameiro

value biotech actelion finance europe 2016 infographic pyramid market cap

News and Trends 26 Apr 2016

Infographic: Which are the most Valuable Biotechs in Europe?

It’s been an interesting year for Biotech, as we repeatedly stress. But there are some biotechs which have been less robust against these tumultuous times, whilst others which have ‘made it big’. As we’ve also started examining individual European cities for an overview of their Biotech community (such as London – and Paris) it is […]

April 26, 2016 - 2 minutesmins - By Dani Bancroft

bioviva ageing gene therapy telomerase parrish

News and Trends 25 Apr 2016

Anti-ageing DIY Gene Therapy may have worked – to an extent…

The weird tale of BioViva‘s CEO receiving non-approved gene therapy to fight ageing has developed further – now with ‘successful results’, which have been verified by two EU research NGOs. There may be something to it after all? Stopping ageing has always been a dream of mankind – and one that is slowly beginning to […]

April 25, 2016 - 3 minutesmins - By Denise Neves Gameiro

astrazeneca centre genomics research hli wellcome fimm

News and Trends 25 Apr 2016

AstraZeneca partners up with Genomics Elite for new Biobank

AstraZeneca has announced it will create a new Centre for Genomics Research in Cambridge (UK) – joining the Wellcome Sanger, a Craig Venter Biotech and a Finnish specialist Institute to do so. AstraZeneca is betting on genomics to transform drug discovery and support its R&D pipeline. The idea is to create a ‘biobank‘ with genome analysis, integrated with data from […]

April 25, 2016 - 3 minutesmins - By Denise Neves Gameiro

kiweno bianca gfrei lecture food intolerance diagnostic

News and Trends 25 Apr 2016

The DIY Allergy Blood Test inspiring Austria’s startup Scene

I got to hear the interesting story and business model of kiweno, a digital health startup and rising star in Austria. What’s the product, where is the demand and were there challenges with perceptions after the Theranos scandal? Berlin has a lot of exciting events to feed the thriving startup scene here. And really at […]

April 25, 2016 - 6 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

EU approves Combo-Drug for Metastatic Colorectal Cancer

French Biotech and Cambridge to improve Food Security with UK Grant

Interviewing the CSO of the newly €90M fund willing to finally tackle Dementia

‘Disappointing results’ for Novartis & MorphoSys phase III in Muscle Disease

French Pleodrug for Rare Neurological Disease opens up phase III trial in US

CAR-T for Lupus with French-Italian Partnership

Interviewing the CEO who uses Probiotics as Needle-free Vaccines

Illumina is Suing over NGS Prenatal Screening… Again

Infographic: Which are the most Valuable Biotechs in Europe?

Anti-ageing DIY Gene Therapy may have worked – to an extent…

AstraZeneca partners up with Genomics Elite for new Biobank

The DIY Allergy Blood Test inspiring Austria’s startup Scene

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!